Nectero Medical

Nectero Therapeutics – Nectero Therapeutics is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).

Nectero Medical is a biotech company in Tempe, United States, founded in 2017. It has raised $115.5M across 2 rounds, most recently a $96.0M Series D in April 2024.

Headquarters
Tempe, Arizona
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$115.5M
Last Round
$96.0M Series DApr 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. to use credits for reveals, or explore the API.

About

Nectero Medical (now Nectero Therapeutics) is a clinical-stage biotech company developing the Nectero EAST® System, a minimally invasive endovascular procedure that delivers a stabilizing agent to strengthen the aortic wall and slow growth of small to medium-sized abdominal aortic aneurysms. The company received FDA Fast Track and Breakthrough Therapy designations in 2023 and raised a $94M Series D to advance its Phase II/III trial.

Funding History

Data from Indexed.vcUpdated
Series DSeries DApr 2024
$96.0M

1 more funding event

  • Series C20211 investor

Funding: Series C through Series D. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nectero Medical on Indexed.vc
<a href="https://indexed.vc/companies/nectero-medical"><img src="https://indexed.vc/api/badge/company/nectero-medical" alt="Nectero Medical on Indexed.vc" width="260" height="76" /></a>